Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBIT (2020 - 2025)

Historic EBIT for Antiaging Quantum Living (AAQL) over the last 6 years, with Q4 2025 value amounting to -$272239.0.

  • Antiaging Quantum Living's EBIT fell 3693.15% to -$272239.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$641108.0, marking a year-over-year increase of 2650.65%. This contributed to the annual value of -$789959.0 for FY2025, which is 9126.55% down from last year.
  • Latest data reveals that Antiaging Quantum Living reported EBIT of -$272239.0 as of Q4 2025, which was down 3693.15% from -$51222.0 recorded in Q3 2025.
  • In the past 5 years, Antiaging Quantum Living's EBIT ranged from a high of -$1520.0 in Q3 2022 and a low of -$272239.0 during Q4 2025
  • Over the past 5 years, Antiaging Quantum Living's median EBIT value was -$29727.0 (recorded in 2023), while the average stood at -$92122.2.
  • Its EBIT has fluctuated over the past 5 years, first surged by 8008.39% in 2022, then tumbled by 351977.05% in 2024.
  • Quarter analysis of 5 years shows Antiaging Quantum Living's EBIT stood at -$19310.0 in 2021, then soared by 64.93% to -$6772.0 in 2022, then tumbled by 1333.74% to -$97093.0 in 2023, then crashed by 104.77% to -$198814.0 in 2024, then crashed by 36.93% to -$272239.0 in 2025.
  • Its EBIT stands at -$272239.0 for Q4 2025, versus -$51222.0 for Q3 2025 and -$138203.0 for Q2 2025.